BRIEF published on 07/02/2024 at 11:36, 2 years 2 months ago ARKEMA : Déclaration sur le Nombre de Droits de Vote et d'Actions au 30 Juin 2024 Droits De Vote Code De Commerce Actions Réglementation Actions Auto-détenues
BRIEF published on 07/02/2024 at 11:36, 2 years 2 months ago ARKEMA: Declaration on the Number of Voting Rights and Shares as of June 30, 2024 Voting Rights Actions Treasury Shares Regulation Trade Code
PRESS RELEASE published on 07/02/2024 at 11:31, 2 years 2 months ago Informations privilégiées / Autres communiqués Déclaration du nombre total de droits de vote et d'actions au 2 juillet 2024 conformément à la réglementation en vigueur Autorité Des Marchés Financiers Nombre D'actions Code De Commerce Information Réglementée Nombre De Droits De Vote
PRESS RELEASE published on 07/02/2024 at 11:31, 2 years 2 months ago Inside Information / Other news releases Press release on total number of shares and voting rights as of June 30, 2024, in accordance with French commercial code and AMF regulations Voting Rights French Commercial Code Shares AMF Regulated Information
BRIEF published on 05/21/2024 at 12:16, 2 years 3 months ago Arkema Discloses Share Buyback Transactions for Mid-May 2024 Share Buyback Financial Disclosure Stock Transactions ARKEMA
BRIEF published on 05/21/2024 at 12:16, 2 years 3 months ago Arkema annonce ses opérations de rachat d'actions pour mi-mai 2024 Rachat D'actions Opérations Boursières Divulgation Financière ARKEMA
PRESS RELEASE published on 05/21/2024 at 12:11, 2 years 3 months ago Inside Information / Other news releases Arkema discloses trading in own shares from 13 May to 14 May 2024, in compliance with regulations. Share buyback details can be found on Arkema's website Share Buyback Investor Relations Trading Compliance ARKEMA
PRESS RELEASE published on 05/21/2024 at 12:11, 2 years 3 months ago Informations privilégiées / Autres communiqués Arkema déclare ses transactions sur actions propres du 13 au 14 mai 2024 selon la réglementation en vigueur. Consultez le site pour plus d'informations Transactions Sur Actions Propres Réglementation Achat D'actions ARKEMA Prix Pondéré Moyen
BRIEF published on 05/15/2024 at 17:55, 2 years 3 months ago L'Assemblée Générale d'Arkema adopte toutes les résolutions proposées Résultats Financiers Stratégie D'entreprise Assemblée Générale Dividende Matériaux De Spécialités
BRIEF published on 05/15/2024 at 17:55, 2 years 3 months ago The Arkema General Meeting adopts all proposed resolutions Financial Results Business Strategy Dividend General Assembly Specialty Materials
Published on 09/10/2026 at 22:25, 11 hours 35 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 18 hours 40 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 19 hours ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 09:20, 40 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 55 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 1 hour ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 3 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 3 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 14 hours 30 minutes ago Availability of the 2026 Interim Financial Report
